Smart Remote Monitoring

HeartBeam, Inc. (NASDAQ: BEAT) is a development stage digital healthcare company with proprietary ECG telemedicine technology that will redefine the way high risk cardiovascular patients are diagnosed in an ambulatory setting at any time and any place. Its breakthrough solution employs a reusable, credit card sized, 3D vector ECG recording device and cloud-based software capable of assisting a physician in diagnosing a wide range of cardiovascular disease. HeartBeam is initially focusing on a huge unmet need of helping diagnose heart attacks in patients outside of a medical institution. No single lead ECG technology can offer this value to patients and their physicians. This underserved market is several times larger than the cardiac arrhythmia detection market based on the prevalence of patients with coronary artery disease at high risk of heart attack. For more information visit www.heartbeam.com.

President & CEO of a medical device start-up company developing an ambulatory ECG monitor.

Developed, implemented, conducted all preclinical and clinical studies worldwide for start up implantable defibrillator company. Performed extensive clinical feasibility trials and acute testing. Gained CE and FDA Panel approval for novel subcutaneous implantable defibrillator. Member of executive team responsible for raising capital to fund the company from 2002-present.

Co-founded a start-up medical distribution company. Established international sales & distribution for small and mid-sized medical device companies in California.

Responsible for all aspects of Sales and Marketing for an ablation company. Established direct US sales force and distributor operations in Europe and Asia.

Responsible for clinical programs worldwide for CPI. Responsible for managing all clinical trials to gain FDA and other regulatory approvals worldwide.

Responsible for clinical trials worldwide for pacemakers, implantable defibrillators, lead systems and programmers.